Bridgelux F90 Series CRI90 deliver industry leading efficacy
Bridgelux announced the commercial release of its F90 Series LED products for commercial lighting which deliver a minimum CRI of 90 combined with industry leading efficacy.
Bridgelux F90 LED products use Potassium Fluorosilicate (PFS) phosphor technology licensed from Current Lighting Solutions, LLC for use in commercial lighting applications.For traditional LED technology, higher CRI results in a lower efficacy. By replacing broadband red nitride phosphor with narrowband red PFS phosphor, the F90 LED products can achieve today’s CRI80 LED efficacy with a CRI of 90. Lighting customers can simply replace their existing LEDs in their lighting products with the new F90 LEDs for CRI90 conversion. Bridgelux’s new family of F90 Series LEDs (Table 1) delivers a CRI of at least 90 and R9 of at least 50.
The F90 2835 0.2W LED has a lumen efficacy ranging from 170 lm/W to 210 lm/W to meet the DLC (Design Lights Consortium) V5.1 Standard for different lighting products including T8 lamps, troffers, high-bay, linear ambient, and case lighting.
Bridgelux F90 LED products use Potassium Fluorosilicate (PFS) phosphor technology licensed from Current Lighting Solutions, LLC for use in commercial lighting applications.For traditional LED technology, higher CRI results in a lower efficacy. By replacing broadband red nitride phosphor with narrowband red PFS phosphor, the F90 LED products can achieve today’s CRI80 LED efficacy with a CRI of 90. Lighting customers can simply replace their existing LEDs in their lighting products with the new F90 LEDs for CRI90 conversion. Bridgelux’s new family of F90 Series LEDs (Table 1) delivers a CRI of at least 90 and R9 of at least 50.
The F90 2835 0.2W LED has a lumen efficacy ranging from 170 lm/W to 210 lm/W to meet the DLC (Design Lights Consortium) V5.1 Standard for different lighting products including T8 lamps, troffers, high-bay, linear ambient, and case lighting.
No comments: